Key result
Among 14 patients with primary sarcomas of the heart and great vessels, 8 responded to treatment, and 3 were alive with no evidence of disease after a median follow-up of 14.5 months.
Observational (n=14)
No
Primary sarcomas of the heart and great vessels have a dismal prognosis, but chemotherapy may offer promising responses in some patients.
No takes yet. Share an insight, caveat, or question.
Responses to chemotherapy in this small cardiac sarcoma cohort support multimodal strategies; leaves optimal regimens open for prospective evaluation.
Mayer et al. (2007) conducted an observational in Primary malignant sarcomas of the heart and great vessels (n=14). Treatment for primary sarcoma (resection and/or chemotherapy) was evaluated on Survival and response to treatment. Among 14 patients with primary sarcomas of the heart and great vessels, 8 responded to treatment, and 3 were alive with no evidence of disease after a median follow-up of 14.5 months.